Cancer Center Announces First Patient Has Received City of Hope's Novel, Potentially Cancer-Stopping Pill
prnewswire.com
news
2022-10-19 14:00:00

The Phase 1 clinical trial tests the safety of providing City of Hope-developed AOH1996 to people with reoccurring solid tumors. 






LOS ANGELES, Oct. 19, 2022 /PRNewswire/ --Â City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in people with reoccurring solid tumors is expected to continue for the next two years.
